ANGELICA WILLIAMS: Open Payments
NPI 1902399702 · BREWTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $166 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| Blueprint Medicines Corporation | 2 | $63 |
| Amgen Inc. | 2 | $42 |
| Genentech USA, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| LEO Pharma Inc. | 1 | $18 |
Products named: AIRSUPRA, TEZSPIRE, AYVAKIT, Xolair, CUVITRU, EBGLYSS, ADBRY, Rhapsido.
Industry payments across AL — which companies pay providers there.
